Article
Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival
4 Nov 2022
Abstract excerpt
Molecular heterogeneity is a key feature of glioblastoma that impedes patient stratification and leads to large discrepancies in mean patient survival. Here, we analyze a cohort of 96 glioblastoma patients with survival ranging from a few months to over 4 years. 46 tumors are analyzed by mass spectrometry-based spatially-resolved proteomics guided by mass spectrometry imaging. Integration of protein expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
